Source: International Congress 2015 – Screening strategies in TB
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Ipek Coskunol (Izmir, Turkey), Ipek Coskunol, Aysegül Baysak, Ayse Dalli, Funda Uluorman, Gerçek Can. Anti-TNF-alpha therapy in patients with latent tuberculosis incidence. Eur Respir J 2015; 46: Suppl. 59, 2969

Member's Comments

No comment yet.

Related content which might interest you: Incidence of tuberculosis among anti-TNF users in patients with previous history of tuberculosis Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III Year: 2013 CT semiotics of respiratory tuberculosis in HIV-infected patients, depending on the degree of immunosuppression Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014 Latent tuberculosis infection prevalence and risk of developing active TB among patients eligible for starting anti-TNFα therapy Source: International Congress 2015 – Screening strategies in TB Year: 2015 Verification of pulmonary tuberculosis in HIV-infected patients with low CD4 Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014 Lag period for diagnosing and starting treatment for pulmonary tuberculosis patients Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Active tuberculosis prevalence and characteristics of tuberculosis patients in liver transplant patients Source: International Congress 2015 – Case series and clinical conundrums in TB Year: 2015 Miliary tuberculosis during treatment with anti TNF alpha - a report of four cases Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013 Restarting biologic agents in rheumatology patients who developed tuberculosis under TNFα-inhibitor treatment Source: International Congress 2015 – Latent TB infection and screening Year: 2015 Tuberculosis in patients receiving treatment of TNF-alpha inhibitors Source: International Congress 2015 – Case series and clinical conundrums in TB Year: 2015 Initiation of anti-TNF therapy within 3 weeks of LTBI treatment in patients with immune-mediated inflammatory diseases Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014 Primary drug resistance of mycobacterium tuberculosis in HIV-positive patients Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA) Year: 2016 Non-tuberculous infections in patients with anti-TNF treatment Source: Annual Congress 2010 - Treatment options for asthma Year: 2010 Extrapulmonary tuberculosis in HIV infected patients admitted to the hospital Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA) Year: 2016 Tuberculosis screening in patients receiving biological therapy Source: International Congress 2015 – Screening strategies in TB Year: 2015 MOTT as a cause of treatment failure in pulmonary tuberculosis Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management Year: 2013 Treatment for latent tuberculosis infection in migrants carries a low risk of hepatotoxicity Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 The feature of BCG complications in children Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013 Advantages of intravenous chemotherapy for tuberculosis patients with viral hepatitis Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 Immune response in children with latent tuberculosis infection and active pulmonary tuberculosis Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014 Side effects of chemical preparations in patients with drug-resistant pulmonary tuberculosis Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders Year: 2015